• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CORPORATION, ASHITAKA R2P MISAGO RX SELF-EXPANDING PERIPHERAL STENT; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CORPORATION, ASHITAKA R2P MISAGO RX SELF-EXPANDING PERIPHERAL STENT; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Model Number N/A
Device Problems Fracture (1260); Material Deformation (2976)
Patient Problems Pain (1994); Stenosis (2263)
Event Date 10/04/2022
Event Type  Injury  
Manufacturer Narrative
Udi: n/a as this product code is not exported to the us market.Implanted date: unknown, explanted date: device was not explanted, device manufacture date: unknown due to unknown lot number.The actual sample was discarded by the involved facility; therefore, the actual device will not be returned for evaluation.Since the involved lot was unknown, it was not possible to investigate the manufacturing history record and the shipping inspection record.Based on the description of the event stating that the product in question was implanted about 1.5 years before the date of occurrence, which was estimated to be april 2021, review of non-conformance report for three years back from april 2021 (may 2018 - april 2021) was performed.As a result, it was confirmed that no deviations or nonconformities related to this event had occurred.Based on the results of the investigation and the description of the event, it was inferred that the stent was not sufficiently expanded at the stenotic site due to some factors (e.G., the indentation left at the same site), which resulted in the fracture of the stent in the way it was crushed inward.However, since the actual sample was not returned, the cause of occurrence could not be clarified.Relevant instructions for use (ifu) reference: "pre-dilatation of the target vessel is recommended." "to assure optimal stent delivery, confirm that the pre-dilation is properly done before stenting patients who have highly tortuous or calcified lesions and/or vessels proximal to the lesion." terumo medical products (tmp) (importer) registration no.(b)(4) is submitting this report on behalf of ashitaka factory of terumo corporation (manufacturer) registration no.(b)(4).
 
Event Description
The user facility reported that the misago device involved was used to treat a stenosis of the left external iliac artery (eia) (near cia).A metacross 6.0/40 was used for pre-dilation.As the lesion was dilated sufficiently, though some indentation was left in the stenotic section, the actual device (misago 10/60) was implanted.An angiographic showed no severe calcification.Since the stenosis was widened to 6 mm and some indentation remained, the procedure was finished.About 18 months later, the patient came to the hospital with intermittent claudication.The patient was unable to walk 100 m.An echo confirmed the stenosis, and the patient underwent revascularization.The stent was not fully expanded at the stenosis and was fractured in a way that it was crushed inward.In the distal section of the stent, some struts were facing outward, which also showed fracture.A wire was able to capture the true lumen, a straight angiographic catheter was inserted, replaced with a 35 wire, a 7 french long sheath was passed in through the stent, and vbx8.0/59 was implanted with dilatations repeated three times.When pressurized at approximately 12 atm, vbx expanded, and the calcified area showed a cracking behavior.The procedure was completed after confirmation by intravascular ultrasound (ivus).The event occurred intra-operative.The patient was not harmed; however, additional medical intervention was required.The procedure outcome was not reported.The final patient impact was not harmed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
R2P MISAGO RX SELF-EXPANDING PERIPHERAL STENT
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
TERUMO CORPORATION, ASHITAKA
150 maimaigi-cho
fujinomiya city, 418
JA  418
Manufacturer (Section G)
TERUMO CORPORATION, ASHITAKA
reg. no. 9681834
150 maimaigi-cho
fujinomiya city, 418
JA   418
Manufacturer Contact
gina digioia
reg. no. 2243441
950 elkton blvd
elkton, MD 21921
6402040886
MDR Report Key15756396
MDR Text Key303296585
Report Number9681834-2022-00219
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P140002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 11/08/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/08/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberN/A
Device Catalogue NumberSX-IMA1060RN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/11/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age63 YR
Patient SexMale
-
-